LCLAT1
Lysocardiolipin acyltransferase 1
Also known as: AGPAT8, ALCAT1, FLJ37965, LCLT1_HUMAN, LPLAT6, LYCAT
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UWP7
- Gene
- LCLAT1
- Ensembl
- ENSG00000172954
- Chromosome
- 2
- Canonical length
- 414 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum,Cytosol
OverviewNCBI Gene
Enables 1-acylglycerol-3-phosphate O-acyltransferase activity. Predicted to be involved in phosphatidylinositol acyl-chain remodeling. Located in cytosol and endoplasmic reticulum. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
414 residues, UniProt reviewed canonical sequence.
>Q6UWP7|LCLAT1
1 MHSRGREIVV LLNPWSINEA VSSYCTYFIK QDSKSFGIMV SWKGIYFILT LFWGSFFGSI
61 FMLSPFLPLM FVNPSWYRWI NNRLVATWLT LPVALLETMF GVKVIITGDA FVPGERSVII
121 MNHRTRMDWM FLWNCLMRYS YLRLEKICLK ASLKGVPGFG WAMQAAAYIF IHRKWKDDKS
181 HFEDMIDYFC DIHEPLQLLI FPEGTDLTEN SKSRSNAFAE KNGLQKYEYV LHPRTTGFTF
241 VVDRLREGKN LDAVHDITVA YPHNIPQSEK HLLQGDFPRE IHFHVHRYPI DTLPTSKEDL
301 QLWCHKRWEE KEERLRSFYQ GEKNFYFTGQ SVIPPCKSEL RVLVVKLLSI LYWTLFSPAM
361 CLLIYLYSLV KWYFIITIVI FVLQERIFGG LEIIELACYR LLHKQPHLNS KKNELocalizationUniProt · AlphaFold · HPA
Whether an antibody against LCLAT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 11 nTPM
- heart muscle: 11 nTPM
- thyroid gland: 10 nTPM
- epididymis: 9.1 nTPM
- kidney: 8.8 nTPM
- small intestine: 8.7 nTPM
Single-cell type
- cardiomyocytes: 322 nCPM
- lactotrophs: 208 nCPM
- proximal tubule cells: 206 nCPM
- cone photoreceptor cells: 172 nCPM
- respiratory ciliated cells: 161 nCPM
- choroid plexus epithelial cells: 160 nCPM
Immune cell
- basophil: 16 nTPM
- naive CD4 T-cell: 12 nTPM
- naive CD8 T-cell: 11 nTPM
- naive B-cell: 9.7 nTPM
- memory CD4 T-cell: 8.2 nTPM
- memory B-cell: 7.4 nTPM
Brain region
- cerebellum: 70 nTPM
- white matter: 69 nTPM
- cerebral cortex: 67 nTPM
- hypothalamus: 66 nTPM
- basal ganglia: 61 nTPM
- hippocampal formation: 58 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.82
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.92
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cardiolipin acyl-chain remodeling
- CDP-diacylglycerol biosynthetic process
- phosphatidic acid biosynthetic process
- phosphatidylinositol acyl-chain remodeling
Molecular functions
- 1-acylglycerol-3-phosphate O-acyltransferase activity
- acyltransferase activity
- O-acyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LCLAT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LCLAT1 as an antibody target. Whether an autoantibody or antibody against LCLAT1 could matter depends on whether native LCLAT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LCLAT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LCLAT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...